Clinical trial · Interventional
Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome
NCT06963840CI-TRIAL-00094267Ova-All Careactive not recruitingPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Theronomic Ova-All Care is a tribiotic health product aimed at improving ovarian health in people with polycystic ovarian syndrome (PCOS). In this study, a total of 16 participants with PCOS diagnosed by a gynaecologist will be invited to take Ova-All Care, two capsule once a day, for 12 weeks. Biomarkers of ovarian health will be measured at baseline, four weeks after the start of the intervention, and at the end of the intervention.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovarian Syndrome (PCOS) | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Theronomic Ova-All Care | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Theronomic Ova-All Care
- description
- Active treatment - Theronomic Ova-All Care
- interventionNames
- Dietary Supplement: Theronomic Ova-All Care
Primary outcomes (1)
- measure
- Serum oestrogen level
- timeFrame
- From enrollment to end-of intervention (Week 12)
- description
- Serum oestrogen levels determined by blood test, pg/mL We will conduct two subgroup analyses with participants with excessively low (less than 25 pg/mL) and excessively high (more than 138 pg/mL) serum oestrogen levels
Secondary outcomes (35)
- measure
- HbA1c
- timeFrame
- From enrollment to end-of intervention (Week 12)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 40 Years
Show eligibility criteria text
Inclusion criteria 1. Women aged 18-40 years 2. Previous diagnosis of PCOS by a gynaecologist 3. Able to take body temperature every day for 12 weeks 4. Able to attend the testing centre every 4 weeks 5. Able to complete online questionnaires Exclusion criteria 1. Pregnancy, lactation; 2. Uterine amenorrhea (such as intrauterine adhesions) 3. Thyroid disease or hyperprolactinemia 4. Liver and kidney dysfunction, autoimmune diseases (such as systemic lupus erythematosus), malignant tumors, mental illness 5. Use of contraceptives, hormone replacement therapy (HRT), immunosuppressants and other drugs that affect ovarian function in the past 3 months. 6. Smokers (\>5 cigarettes per day), alcoholics; 7. Unable to cooperate with follow-up or refuse to sign informed consent.
References
Publications (0)
Data not yet available
No reference posted for this study.